Aurora Cannabis (ACB) vs Cronos Group (CRON)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Cronos Group (CRON) has outperformed Aurora Cannabis (ACB) over the past year, gaining 28.3% versus a loss of 1.2%. Over five years, CRON leads with a -34.9% price change compared with -93.9% for ACB. Cronos Group is the larger company by market cap ($1.11 billion vs $273.5 million), about 4.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACB | CRON |
|---|---|---|
| Share price | $4.16 | $3.04 |
| Market cap | $273.50M | $1.11B |
| 1-day change | -2.35% | -1.30% |
| YTD return | -1.42% | +15.59% |
| 1-year return | -1.19% | +28.27% |
| 5-year return | -93.87% | -34.90% |
| P/E ratio (TTM) | — | 19.00 |
| EPS (TTM) | $-0.19 | $0.16 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $146.59M |
| Revenue growth (YoY) | — | +24.63% |
| Net income (latest FY) | — | $-9.45M |
| Gross margin | — | 42.81% |
| Operating margin | — | -11.87% |
| Net margin | — | -6.44% |
| 52-week high | $6.36 | $3.91 |
| 52-week low | $2.56 | $2.35 |
| Distance from 52-week high | -34.59% | -22.25% |
| Analyst consensus | underperform | strong_buy |
| Avg. price target upside | — | -3.62% |
| Average volume | 1.31M | 1.07M |
| Shares outstanding | 65.74M | 366.47M |
| Employees | 1,028 | 610 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cronos Group is about 4.1 times larger than Aurora Cannabis by market value ($1.11B vs $273.50M).
- CRON has outperformed ACB by 29.5 percentage points over the past year.
About Aurora Cannabis
ACB stock →Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.
Health Care · Medicinal Chemicals and Botanical Products · 1,028 employees
About Cronos Group
CRON stock →Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names.
Health Care · Medicinal Chemicals and Botanical Products · 610 employees
ACB vs CRON FAQ
Which is bigger, Aurora Cannabis or Cronos Group?
Cronos Group (CRON) is larger, with a market capitalization of $1.11B compared with $273.50M for Aurora Cannabis (ACB).
Which stock has performed better over the past year, ACB or CRON?
CRON returned +28.27% over the past 12 months, compared with -1.19% for ACB (price return, excluding dividends). Past performance does not predict future results.
Are Aurora Cannabis and Cronos Group in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.